Abstract
Despite its own assertions to ADAW that it is moving in the right direction even with only an acting director (Regina LaBelle, who is esteemed for her public health, harm reduction, knowledge of federal affairs and diplomacy), the Office of National Drug Control Policy (ONDCP) is under pressure from virtually all organizations in the field to have a permanent director. The following organizations are included as signatories in a May 26 letter, a copy of which was obtained by ADAW, calling on the White House to nominate someone — now. The ONDCP did not explain the delay despite repeated requests for an interpretation of this.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
